Abstract:Aberrant expression of SIRT1, H3K9me3, H3K9Ac and E-cadherin is considered to be associated with tumorigenesis and survival outcomes. In this study, we aim to investigate the expression of SIRT1, H3K9me3, H3K9Ac and E-cadherin and their associations with clinicopathological features in gastric cancer. A total of 105 gastric cancer samples were obtained from patients underwent gastrectomy. Twenty corresponding normal adjacent tissues were simultaneously taken as control. The expression of SIRT1, H3K9me3, H3K9Ac and E-cadherin in these tissues was detected by immunohistochemical and their correlations with clinicopathological features were analyzed. Significant increase of SIRT1 expression was noted in gastric cancer compared with that of normal adjacent tissues (P<0.001). SIRT1 expression was markedly associated with tumor invasion depth (P=0.026), lymph node metastasis (P=0.001), clinical stage (P=0.004) and survival time (P=0.029). No significant difference was identified in the expression of H3K9Ac between gastric and normal tissues. Furthermore, the expression of H3K9Ac was unrelated with gender, age, tumor size, differential degree, invasion depth, lymph node metastasis, clinical stage and survival time (P>0.05). However, H3K9me3 expression was significantly higher in gastric cancer than that in normal tissues (P<0.001), and was remarkably correlated with tumor size (P=0.004), invasion depth (P=0.003), clinical stage (P=0.027) and survival time (P=0.013). In contract, the strong-positive expression of E-cadherin was significantly lower in gastric cancer than that in normal tissues (P<0.05), and its expression was markedly associated with tumor size (P=0.015), differential degree (P=0.031), tumor invasion depth (P<0.001), lymph node metastasis (P<0.001), clinical stage (P<0.001) and survival time (P<0.001). Meanwhile, SIRT1 expression was positively correlated with H3K9me3 (r=0.402, P<0.001), while E-cadherin was negatively associated with SIRT1 (r=-0.285, P=0.003) and H3K9me3 (r=-0.303, P=0.002). Aberrant expression of SIRT1, H3K9me3 and E-cadherin was closely associated with the progression and prognosis in patients with gastric cancer. Also, the expression of such factors were mutually related, based on which may provide an alternative strategy for the clinical diagnosis and treatment by the regulation of their expression in gastric cancer.

Sirtuin-4 (SIRT4) is Downregulated and Associated with Some Clinicopathological Features in Gastric Adenocarcinoma.

SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism

SIRT1 Is downregulated in gastric cancer and leads to G1-phase arrest via NF-kB/Cyclin D1 signaling

SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism via the MEK/ERK/C-Myc Axis

Decreased sirtuin 4 levels promote cellular proliferation and invasion in papillary thyroid carcinoma

Expressions of SIRT 1, E-cadherin and MLH 1 in Gastric Cardia Carcinoma and Their Relationship

SIRT3 Inhibits Cell Proliferation in Human Gastric Cancer Through Down-Regulation of Notch-1.

Expressions of SIRT1 As Prognostic Biomarker on Resectable Gastric Cancer Patient

Sirtuin 4 Depletion Promotes Hepatocellular Carcinoma Tumorigenesis Through Regulating Adenosine-Monophosphate-Activated Protein Kinase Alpha/Mammalian Target of Rapamycin Axis in Mice

Expression Of Sirt1 In Gastric Cardiac Cancer And Its Clinicopathologic Significance

Expression of Smad4 in Gastric Adenocarcinoma and Its Clinical Significance

Association of sirtuins with clinicopathological parameters and overall survival in gastric cancer.

Sirtuin Expression is Downregulated in Non‐small Cell Lung Cancer

GCNT4 is Associated with Prognosis and Suppress Cell Proliferation in Gastric Cancer

Sirtuin 4 Activates Autophagy and Inhibits Tumorigenesis by Upregulating the P53 Signaling Pathway

SIRT1 Inhibits Gastric Cancer Proliferation and Metastasis Via STAT3/MMP‐13 Signaling

Expression of SIRT 1 , H 3 K 9 me 3 , H 3 K 9 Ac and E-cadherin and its correlations with clinicopathological characteristics in gastric cancer patients

Sirtuin 4 Inhibits Prostate Cancer Progression and Metastasis by Modulating p21 Nuclear Translocation and Glutamate Dehydrogenase 1 ADP-Ribosylation

Clinicopathological Significance of SIRT1 Expression in Colorectal Adenocarcinoma

Study on the Clinicopathologic Significance and Expression of SIRT1

Co-Ordinated Overexpression of Sirt1 and Stat3 is Associated with Poor Survival Outcome in Gastric Cancer Patients